Nucleation-Controlled Ostwald Ripening with Polymer Inhibition Predicts ASD Phase Evolution Trajectories

Two fields that seem worlds apart — the chemistry of volcanic glass slowly dissolving in ocean water, and the science of making hard-to-dissolve drugs actually work in patients — may share a deeper mathematical logic. Many modern drugs are nearly insoluble in water, so pharmaceutical scientists engineer them into 'amorphous solid dispersions' (ASDs): a carefully disordered mixture of the drug blended with a protective polymer, like catching a drug molecule mid-crystallization and freezing it there. This glassy, unstable form dissolves faster, but understanding exactly *how* and *when* it dissolves has been more art than science. This hypothesis borrows a precise equation that geochemists use to describe how volcanic glass breaks down in seawater — a framework developed in the 1980s called Transition State Theory — and proposes it can predict drug dissolution from these polymer-drug mixtures. The key insight is that at low drug concentrations (below about 20%), the slowest step in dissolution is breaking the molecular handshake between the drug and polymer at the surface — just like breaking silicon-oxygen bonds in volcanic glass. A single mathematical criterion (called the Damköhler number, essentially a ratio of reaction speed to diffusion speed) would tell formulators which regime they're in and which equation to use. What makes this clever is the specificity: the hypothesis isn't just saying 'these two things are similar.' It proposes testable numbers — specific energy barriers, specific crossover points in drug loading — borrowed from geology and adapted to pharmacy. If volcanic glass and drug tablets really do obey the same dissolution physics, it would mean decades of geochemical data could be mined to fast-track drug formulation science.

This is an AI-generated summary. Read the full mechanism below for technical detail.